Company: HCWB
Filing Date: 2025-02-21
Form Type: DEF 14A
Source: 0001193125-25-032115
Chunk: 38

Company: HCW Biologics Inc.
Filing Date: 2025-02-21
Form: DEF 14A
Chunk 38
---
 without limitation, documents, formulae,
business information, trade secrets, technology, strategies, prototypes, samples, plant, and equipment), which may or may not be designated as “Confidential,” “Proprietary” or some similar designation. Information communicated
orally shall be considered Confidential Information. Confidential Information may also include information disclosed by third parties. Confidential Information shall not, however, include any information which (i) was publicly known and made
generally available in the public domain prior to the time of disclosure by the disclosing party; (ii) becomes publicly known and made generally available after disclosure by the disclosing party to the receiving party through no fault, action
or inaction of the receiving party; (iii) is already in the possession of the receiving party at the time of disclosure by the disclosing party as shown by the receiving party’s files and records immediately prior to the time of
disclosure; (iv) is obtained by the receiving party from a third party without a breach of such third party’s obligations of confidentiality; (v) is independently developed by the receiving party without use of or reference to the
disclosing party’s Confidential Information, as shown by documents and other competent evidence in the receiving party’s possession; or (vi) is required by law to be disclosed by the receiving party, provided that the receiving party
gives the disclosing party prompt written notice of such requirement prior to such disclosure and assistance in obtaining an order protecting the information from public disclosure.

“” shall have the meaning set forth in .

“” means any receiver, trustee, assignee, liquidator, or similar official under any Bankruptcy Law.

“” shall mean any loss, claim, damage, liability, cost, and expense (including, without limitation, reasonable
attorneys’ fees and disbursements and costs and expenses of expert witnesses and investigation).

“”
shall have the meaning specified in .

“” shall have the
meaning specified in .

- A-2 -

“” shall mean The Depository Trust Company, or any successor performing
substantially the same function for the Company.

“” shall mean the DTC’s Fast Automated Securities
Transfer Program.

“” shall mean Deposit Withdrawal at Custodian as defined by the DTC.

“” shall mean that (a) the Common Stock is eligible at DTC for full services pursuant to DTC’s
operational arrangements, including, without limitation, transfer through DTC’s DWAC system, (b) the Company has been approved (without revocation)